Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IDN 5243 in Low Back Pain
NCT02568826Phase 2Withdrawn
- Sponsor
- Indena
- Start
- Apr 2016
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of IDN 5243 in low back pain (LBP), sponsored by Indena. Primary endpoints: Safety (vital signs, laboratory evaluations and incidence of adverse events) and Local tolerability. Planned start Apr 2016; status: withdrawn.
02
Drugs
IDN 5243
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT02568826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02568826.